Avoidance of general anaesthesia for breast surgery may be because of clinical reasons or patient choice. There is emerging evidence that the use of regional anaesthesia and the avoidance of volatile anaesthetics and opioid analgesia may have beneficial effects on oncological outcomes. We conducted a prospective observational case series of 16 breast cancer surgeries performed under thoracic paravertebral plus pectoral nerve block with propofol sedation to demonstrate feasibility of technique, patient acceptability and surgeon satisfaction. Fifteen out of 16 cases were successfully completed under sedation and regional anaesthesia, with one conversion to general anaesthesia. Eleven out of 16 cases required low-dose intra-operative opioid analgesia. Out of the 15 surgical procedures completed under regional anaesthesia with sedation, all patients experienced either no or minimal intra-operative pain, and all would choose this anaesthetic technique again. Surgeon-reported operating conditions were 'indistinguishable from general anaesthesia' in most cases, and surgeons were 'extremely satisfied' or 'satisfied' with the technique after every procedure. Combined thoracic paravertebral plus pectoral nerve block with intra-operative sedation is a feasible technique for breast surgery.
Introduction
Breast cancer is the most common cancer in women worldwide, with almost 1.7 million diagnoses in 2012 [1] . In the UK, over 55,000 new cases of invasive breast cancer were reported in 2014, with a trend to an increasing annual incidence [1] . Surgery for breast cancer ranges from breast-conserving surgery to mastectomy, and axillary interventions range from sentinel node biopsy to complete axillary lymph node dissection. Over 35% of patients endure clinically meaningful acute postoperative pain following breast surgery [2] . Persistent pain after breast surgery has an observed incidence of 20-30% [3, 4] , and has been reported to be as high as 60% if adjuvant radiotherapy is administered [5] . As well as nerve damage and radiotherapy, acute postoperative pain has been identified as a risk factor for chronic pain after breast cancer treatment [5] and peri-operative analgesic strategies have historically been opioid based.
Regional anaesthesia has been used and studied extensively in breast surgery as an opioid-sparing strategy, with block of the intercostal supply by thoracic paravertebral block (TPVB) becoming a popular technique [6] . New fascial plane blocks have been developed as alternative or supplementary techniques for chest wall analgesia, including the pectoral nerve blocks (PECS 1 and PECS 2) and serratus plane block [7, 8] . These fascial plane blocks are simple to perform, with fewer potentially serious adverse effects compared with TPVB [9] . Use of regional techniques, either alone or in combination, may reduce opioid requirements and potentially the incidence of chronic pain [10] . Regional anaesthesia might also reduce the incidence of cancer recurrence through opioid-sparing effects or direct mechanisms. This has been studied in relation to TPVB and is currently the subject of a prospective trial [11, 12] . Additionally, the use of volatile agents has been implicated in the progression of minimal residual disease and the use of total intravenous anaesthesia (TIVA) has been recommended [13] . Furthermore, patient-reported outcome measures appear to be improved with TPVB and TIVA [14, 15] .
Almost half of new breast cancer diagnoses each year occur in those aged ≥ 65 years [1] , with comorbid medical conditions being more likely in this age group. It is not uncommon for patients presenting for breast cancer surgery to be at high risk of peri-operative morbidity and mortality. The demand for 'awake surgery' in our institution has been increasing, both to reduce peri-operative risk and to cater for patient request. We have, therefore, developed a novel approach to allow surgery with ultrasound-guided TPVB plus PECS-2 block under sedation.
There are few published data on the use of TPVB with PECS-2 regional anaesthesia for breast surgery. The generalisability and the impact on patient and operator satisfaction remain unknown. We therefore conducted a prospective observational case series to describe the feasibility, utility, patient acceptability and surgeon satisfaction of combined TPVB plus PECS-2 block for breast cancer surgery.
Methods
Our centre routinely offers breast surgery under combined paravertebral and pectoral nerve block with sedation to suitable patients. Research ethics committee review was, therefore, formally waived for this prospective observational study, as patients were offered usual anaesthetic care. However, approval was gained from our institutional audit committee and research and development department. This study followed the preferred reporting of case series in surgery (PROCESS) guidelines [16] and all data management adhered to the Declaration of Helsinki [17] .
All patients undergoing surgery for breast cancer between August 2016 and September 2017 were approached by their anaesthetist on the day of surgery to discuss anaesthetic options. If clinically indicated, or patient choice was for a regional block plus sedation, patients were provided with an information sheet and consent form for participation in this prospective observational case series.
Consenting patients were brought to the anaesthetic room for block performance and standard monitoring was applied [18] . Intravenous (i.v.) access was secured and sedation with midazolam 1-2.5 mg and fentanyl 25-75 lg was administered. Under strict aseptic conditions a single-injection TPVB followed by a PECS-2 block was carried outunder ultrasound guidance. All blocks were carried out by anaesthetists with experience and training in TPVB and PECS-2 techniques.
The TPVB was sited at the T2-T3 or the T3-T4 intercostal level with patients either in the sitting or in the lateral decubitus position using a parasagittal or transverse in-plane approach as outlined previously [19, 20] . A 90-mm 18-gauge SonoTAP Tuohy needle (PAJUNK GmbH Medizintechnologie, Geisingen, Germany) was inserted under continuous in-plane ultrasound guidance towards the paravertebral space, with intermittent hydrolocation using sterile saline solution until pleural displacement was observed; 10 ml levobupivacaine 0.5% mixed with 10 ml lidocaine 2% with 1:200,000 adrenaline was then injected into the paravertebral space, with confirmation of negative aspiration. Sonographic evidence of local anaesthetic spread was sought after the completion of injection.
The PECS-2 block was performed with patients supine, using a 6-13 MHz linear probe and 80-mm Stimuplex â Ultra 360 ™ needle (B. Braun Melsungen AG, Melsungen, Germany) based on the technique described by Blanco et al. [7] . A total volume of 30 ml local anaesthetic (50:50 mixture of levobupivacaine 0.5%/lidocaine 2% with 1:200,000 adrenaline) was used for the block (10 ml between pectoralis major and minor and 20 ml between pectoralis minor and serratus anterior); this was modified accordingly for patients of lower weight.
Patients were transferred to the operating room after performing the blocks without formal dermatomal testing; adequacy was determined by sonographic confirmation of local anaesthetic spread. A propofol target-controlled infusion (TCI) was started and titrated to effect in all cases using the Marsh model. Further doses of fentanyl 25-50 lg were provided intra-operatively if patients reported discomfort and supplemental oxygen was administered via a facemask with incorporated capnography monitoring. Patients were administered i.v. paracetamol and dexamethasone unless contra-indicated.
We recorded baseline patient characteristics, and anaesthetic and surgical data, including details of blocks performed and sedation used. Data regarding further analgesic administration (paracetamol, intraand postoperative i.v. fentanyl or additional local anaesthetic administration by the surgical team) were also recorded. Sedation was recorded at 5-min intervals using the four-point modified Wilson Sedation Scale [21] . At conclusion of surgery, the operating surgeon was asked to grade their satisfaction with the quality of the anaesthetic on a five-point Likert scale (extremely satisfied, satisfied, neither satisfied nor unsatisfied, unsatisfied, extremely unsatisfied) and to compare the quality of the operating conditions on a three-point scale (indistinguishable from general anaesthesia, slightly challenging/adequate, extremely challenging/inadequate). Patients were taken to the recovery area at the end of the procedure, and pain scores were assessed using an 11-point verbal rating scale (VRS) (0 = 'no pain' and 10 = 'worse pain imaginable'). Patient perception of quality of anaesthesia was assessed using the Perception of Quality in Anaesthesia (PQA) questionnaire [22] . Patients were also asked if they would have this type of anaesthetic again. The length of time taken to meet local recovery discharge criteria was also recorded. Local recovery discharge criteria involve a minimum of two 15-min interval observations meeting all of the following parameters: heart rate 51-90 beats. 
Results
Fifteen patients undergoing 16 surgical procedures consented to participate in this case series (Table 1) . Thirteen patients had the TPVB with PECS-2 technique by choice. One patient with multiple comorbidities (severe left ventricular impairment with ejection fraction 20% and chronic kidney disease) who was unfit for general anaesthesia and one patient whose surgery was previously cancelled after an unanticipated failed tracheal intubation, successfully had surgery using this technique. All patients were deemed to have successful TPVB and PECS-2 blocks at first attempt based on the sonographic appearance of local anaesthetic spread. There were no complications noted. The time taken for performance of the blocks is shown in Table 2 .
Fourteen patients received i.v. paracetamol and dexamethasone. Thirteen patients did not feel any pain during the operation, two reported mild pain and one moderate pain. One patient who had wide local excision with axillary node clearance required supplemental local anaesthetic infiltration by the surgeon. The incision was in the inframammary fold so the block was thought to One patient who had a total mastectomy with axillary node clearance required conversion to general anaesthesia. In this case, the incision was medial on the chest wall. Despite a supplementary pre-operative pecto-intercostal fascial block, pain was felt early in the procedure prompting conversion to general anaesthesia. Excluding the patient who required conversion to general anaesthesia, sedation levels were recorded as 'orientated' in 11 patients and 'drowsy' in four patients.
Excluding the general anaesthesia case, median (IQR [range]) time spent in recovery before meeting local discharge criteria was 46. (Table 2) .
Twelve patients had a day-case procedure. All patients stated that they would choose to have this type of anaesthetic again.
Surgeons were extremely satisfied with the operating conditions in 13 out of the 15 successful awake cases and satisfied in the remaining two. Surgical conditions were deemed indistinguishable from general anaesthesia in 11 out of the 15 cases and slightly challenging or adequate in the remaining four.
There were no late complications relating to the TPVB and PECS-2 blocks reported.
Discussion
We have demonstrated that it is feasible to perform major breast surgery with single-injection TPVB and PECS-2 blocks under sedation. This is particularly relevant in the context of breast cancer surgery, as a majority of these patients are elderly and may have comorbidities that make general anaesthesia either undesirable or unsafe. Additionally, there is emerging evidence that volatile anaesthetics may be linked with cancer recurrence [23] , providing a greater impetus to use regional anaesthetic techniques.
To provide successful regional anaesthesia to the breast, a detailed understanding of the nerve supply to the breast is required (Fig. 1) . The skin of the breast, breast gland and nipple are supplied by the second to sixth intercostal nerves (T2-T6) which are adequately blocked with TPVB. The skin overlying the axillary tail of the breast may also have cross-innervation from the intercostobrachial nerve (T1-T2), which is not reliably blocked by TPVB. The pectoralis major and minor muscles underlie the breast, and are supplied by the medial (C8-T1) and lateral (C5-C7) pectoral nerves. These muscles may be dissected or retracted during major axillary and reconstructive surgery. Equally, the serratus anterior may be retracted during surgery and this muscle is supplied by the long thoracic nerve (C5-C7). The medial pectoral, lateral pectoral and long thoracic nerves arise from the brachial plexus, and although they may be blocked by cranial spread of the TPVB injectate, they are more reliably blocked distally via a PECS-2 block. This is particularly important if the surgery is extensive or extends into the axilla.
There are only two published studies describing general anaesthesia-free surgery for breast cancer. One reports a case series using TPVB and sedation for breast surgery [24] . The authors performed either single or multilevel injections and used propofol or remifentanil TCI for sedation with prilocaine top-ups administered by the surgical team as needed. The authors noted that the lateral chest wall was often spared with this technique and postulated that a PECS-2 block would increase coverage. Another study compared general anaesthesia with monitored anaesthesia care (sedation using propofol and remifentanil TCI) coupled with multilevel TPVB and intra-operative surgical local anaesthetic infiltration for breast cancer surgery [25] . Deep levels of sedation were targeted (bispectral index 50-70) and respiratory depression was seen in some patients, including one patient who required airway instrumentation. The authors commented that a combination of TPVB and either general anaesthesia or monitored anaesthesia care would be suitable for day-case surgery, although ambulatory surgery was not performed in their centre.
In contrast to these two studies, all our patients received single-level TPVB and single-injection PECS-2 blocks pre-operatively with no surgical tops-up routinely employed, no intra-operative opioid infusion and only light propofol sedation. Additionally, our centre often performs major breast surgery on an ambulatory basis and there were no exclusions based on age or comorbidities. One of the primary advantages of our technique is the ability to provide safe ambulatory surgery for patients with significant medical comorbidities. Moreover, the combined TPVB and PECS-2 technique was highly acceptable to patients and associated with high levels of satisfaction among surgeons. Since patients received only single-level, ultrasound-guided TPVB, the risk of pleural puncture lower than with a multiple injection technique [26] . The combination of TPVB and PECS-2 also provides excellent postoperative analgesia in the majority of patients, including those undergoing mastectomy and axillary node clearance.
There are some limitations to the TPVB/PECS-2 technique. First, the short peri-operative time might not reflect practice in other centres and patient acceptance of this technique may be altered with longer durations of surgery. Second, although patients did not routinely require local anaesthetic supplementation, 11 patients required intra-operative fentanyl boluses; importantly, this did not have any impact on patient acceptance. Third, in order to maintain a standardised volume of 30 ml local anaesthetic for PECS-2 infiltration, some patients received larger doses of local anaesthetic. However, both injectate mixtures (TPVB and PECS-2) contained dilute adrenaline which would have attenuated systemic absorption, and no patients exhibited signs or symptoms of local anaesthetic toxicity. Fourth, one patient required intra-operative local anaesthetic supplementation, and one patient required conversion to general anaesthesia. It is, therefore, possible that this technique might not reliably provide anaesthesia for medial chest wall surgery and testing dermatomal spread after block performance may be important. Fifth, despite there being a total of five surgeons performing the range of operations, it may not be possible to generalise the conclusions regarding surgical satisfaction to other institutions. Similarly, although no complications were recognised, the limited number of patients is not adequate to prove that the technique is safe; this will require larger, prospective randomised controlled clinical trials. Finally, we have reported short-term outcomes, but long-term outcomes warrant exploration, including the incidence of chronic pain, and cancer-related outcomes. Despite these potential limitations, this technique provides an exciting avenue to explore and we believe it is an important addition to the armoury of anaesthetists.
In conclusion, we have demonstrated the feasibility of an alternative anaesthetic technique for breast surgery, incorporating TPVB and PECS-2 blocks. This technique has been performed successfully and is associated with high levels of patient acceptability and surgeon satisfaction.
